Eyewash Station Additive Concentrate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65785-034 -
Package NDC
65785-034-01 -
Application number
M018 -
SPL ID
445cd72e-831c-98c4-e063-6294a90a7bdc -
SPL set ID
362a6b6d-862d-4322-87a8-5b3a07fbe174 -
UNII
MOR84MUD8E -
UNII
6DC9Q167V3
What the source publishes
- Labeler
- Niagara Pharmaceuticals Inc.
- Active ingredients
- Chlorhexidine gluconate and Propylene Glycol
- Form
- LIQUID
- Routes
- OPHTHALMIC
- Administrative status
- present-in-source-snapshot
- Marketing status
- OTC MONOGRAPH DRUG
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
- Eyewash Station Additive Concentrate
- Chlorhexidine gluconate and Propylene Glycol
- CHLORHEXIDINE GLUCONATE
- PROPYLENE GLYCOL
Complete source data
{
"name": "Eyewash Station Additive Concentrate",
"splId": "445cd72e-831c-98c4-e063-6294a90a7bdc",
"labels": [
{
"setId": "362a6b6d-862d-4322-87a8-5b3a07fbe174",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=362a6b6d-862d-4322-87a8-5b3a07fbe174",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=362a6b6d-862d-4322-87a8-5b3a07fbe174"
}
],
"routes": [
"OPHTHALMIC"
],
"labeler": "Niagara Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": ".236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01)",
"package_ndc": "65785-034-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20111115"
}
],
"productId": "65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc",
"useDomain": "unknown",
"dosageForm": "LIQUID",
"productNdc": "65785-034",
"deaSchedule": null,
"genericName": "Chlorhexidine gluconate and Propylene Glycol",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CHLORHEXIDINE GLUCONATE",
"strength": "145.6 kg/2800L"
},
{
"name": "PROPYLENE GLYCOL",
"strength": "280 kg/2800L"
}
],
"applicationNumber": "M018",
"marketingCategory": "OTC MONOGRAPH DRUG",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20111115",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"unii": [
"MOR84MUD8E",
"6DC9Q167V3"
],
"spl_set_id": [
"362a6b6d-862d-4322-87a8-5b3a07fbe174"
],
"manufacturer_name": [
"Niagara Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc"